Patients will now permanently be able to access take-home doses of methadone, which will reduce clinic visits and increase adherence, according to HHS’ Substance Abuse and Mental Health Services Administration.
The allowance also permits methadone to be prescribed over video telehealth visits and buprenorphine to be prescribed through phone call telehealth appointments. Patients will no longer need to prove a yearlong history of addiction, either.
The rule will become effective April 2, and the compliance date is Oct. 2, according to a notice published in the Federal Register.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
